Skip to content

Dilated Cardiomyopathy 1p C1835928

Published: July 22, 2026Updated: August 20, 2026

A genetic heart condition where the main pumping chamber enlarges and weakens, reducing blood flow. It can run in families. Treatment includes medications, pacemakers, or heart transplant.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
B33.24
ICD-11
1A00.0
Body system
cardiovascular
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Chest discomfort or palpitations

(cardiovascular)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Dyspnea (shortness of breath)

(cardiovascular)

Fatigue

(cardiovascular)

Peripheral edema

(cardiovascular)

Palpitations

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Disease management and monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Diuretic Therapy

Diuretics help remove excess fluid from the body, reducing pulmonary congestion and peripheral edema. They provide rapid symptom relief but do not modify disease progression.

medication
3

Fluid Restriction

Restricting daily fluid intake complements diuretic therapy and helps prevent volume overload. Patients track intake to maintain target levels based on body weight and severity.

lifestyle

Additional treatment options

Cardiac Rehabilitation

Structured exercise programs improve cardiovascular fitness and quality of life under medical supervision. Programs include graduated activity with continuous monitoring.

physical_therapy

BNP/NT-proBNP Monitoring

Regular B-type natriuretic peptide testing helps assess disease severity and treatment response. Rising levels may indicate need for therapy adjustment.

monitoring

Heart Transplant Evaluation

Comprehensive evaluation determines candidacy for cardiac transplantation in advanced disease. Multidisciplinary assessment includes cardiac, pulmonary, and psychosocial evaluation.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Dilated Cardiomyopathy 1p C1835928?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Dilated Cardiomyopathy 1p C1835928. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy